Verition Fund Management
FLNA

Verition Fund Management’s Filana Therapeutics FLNA Stock Holding History

Verition Fund Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.5K Buy
38,144
+10,900
+40% +$22.4K ﹤0.01% 2089
2025
Q4 		$53.9K Sell
27,244
-4,393
-14% -$14.1K ﹤0.01% 3375
2025
Q3 		$92.1K Hold
31,637
– – ﹤0.01% 3607
2025
Q2 		$57.3K Sell
31,637
-103,529
-77% -$184K ﹤0.01% 3523
2025
Q1 		$203K Sell
135,166
-11,770
-8% -$29.7K ﹤0.01% 3045
2024
Q4 		$347K Buy
+146,936
New +$2.58M ﹤0.01% 2691
2023
Q4 		– Sell
-25,100
Closed -$418K – 2638
2023
Q3 		$418K Buy
+25,100
New +$497K ﹤0.01% 1540
2022
Q1 		– Sell
-4,867
Closed -$213K – 2994
2021
Q4 		$213K Buy
+4,867
New +$255K ﹤0.01% 2217
2015
Q3 		– Sell
-2,847
Closed -$34K – 694
2015
Q2 		$34K Buy
+2,847
New +$39K 0.01% 595

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Verition Fund Management's FLNA Position: Q1 2026 in Review

Verition Fund Management increased its Filana Therapeutics (FLNA) stake by 40% in Q1 2026, buying an estimated $22.4K and bringing the position to 38,144 shares worth $64.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Verition Fund Management first reported a position in FLNA in Q2 2015 and has held it in 9 quarters since. The position peaked at $418K in Q3 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Verition Fund Management held 38,144 shares of Filana Therapeutics worth $64.5K as of Q1 2026.
  • Verition Fund Management bought 10,900 Filana Therapeutics shares in Q1 2026, an estimated $22.4K.
  • Filana Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #2089 holding.
  • Verition Fund Management first reported a position in Filana Therapeutics in Q2 2015 and has held it in 9 quarters since.
  • Verition Fund Management's Filana Therapeutics position peaked at $418K in Q3 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.